James Investment Research Inc. Has $368,000 Stock Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

James Investment Research Inc. increased its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 96.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 19,776 shares of the real estate investment trust’s stock after acquiring an additional 9,711 shares during the period. James Investment Research Inc.’s holdings in Sabra Health Care REIT were worth $368,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the business. Family Firm Inc. acquired a new stake in Sabra Health Care REIT during the second quarter valued at approximately $26,000. GAMMA Investing LLC boosted its stake in Sabra Health Care REIT by 40.0% in the 2nd quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust’s stock valued at $57,000 after buying an additional 1,052 shares in the last quarter. International Assets Investment Management LLC grew its position in Sabra Health Care REIT by 1,761.0% in the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 5,776 shares during the period. Future Financial Wealth Managment LLC acquired a new position in Sabra Health Care REIT during the third quarter worth $130,000. Finally, Point72 Hong Kong Ltd acquired a new position in Sabra Health Care REIT during the second quarter worth $117,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Trading Down 3.9 %

Shares of SBRA opened at $18.64 on Friday. The stock’s fifty day simple moving average is $18.21 and its 200-day simple moving average is $16.17. The firm has a market capitalization of $4.37 billion, a PE ratio of 45.46, a price-to-earnings-growth ratio of 2.77 and a beta of 1.25. Sabra Health Care REIT, Inc. has a 12-month low of $12.83 and a 12-month high of $19.78. The company has a quick ratio of 4.27, a current ratio of 4.27 and a debt-to-equity ratio of 0.89.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.24). Sabra Health Care REIT had a return on equity of 3.50% and a net margin of 14.20%. The business had revenue of $176.14 million for the quarter, compared to analyst estimates of $166.54 million. During the same quarter in the prior year, the firm earned $0.34 EPS. The firm’s quarterly revenue was up 9.3% compared to the same quarter last year. As a group, research analysts predict that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.44%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.69%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on SBRA shares. Citigroup raised shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their target price for the stock from $17.00 to $20.00 in a report on Friday, September 13th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Truist Financial lifted their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Scotiabank increased their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Friday, October 11th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Sabra Health Care REIT currently has an average rating of “Moderate Buy” and a consensus target price of $18.38.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.